课题基金 / 基金详情

SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT

SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT
Sprouty,WT1 增长和发展的目标
批准号:
6626675
负责人:
Jonathan D. Licht
金额:
$32.23万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 2005-12-31

项目摘要

项目成果

Jonathan D. Licht的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) In this proposal we will characterize the expression of sprouty in renal development, murine development in general and in Wilm's tumors. We will characterize the mechanism of action of sprouty. Hence we will determine if sprouty is a growth inhibitor which may mediate some of the effects of WT1. We will determine at which steo in signaling through receptor tyrosine kinase sprouty acts. We then isolate partner proteins of spry which will lead to better idea of the molecular mechanism of sprouty. In order to determine the role of spry in normal and aberrant development we will determine in cell culture models and transgenic animals if engineered expression of spry interferes with normal renal morphogenesis. Finally to provide a critical role of sprouty as a target of WT1 important for renal development we will create knockout animals for sprouty one using conditiona cre-lox technology. Through these studies we will characterize an exciting molecule involved isgnal transduction and development. Spry may present a target for future strategies against Wilm's tumor, other malignancies and renal disorder such as polycystic kidney disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UF Health Cancer Center Support Grant - Training Navigator Supplement
  • 批准号:
    10892335
  • 项目类别:
  • 资助金额:
    $19.59万
  • 财政年份:
    2023
  • 负责人:
    Jonathan D. Licht
  • 依托单位:
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
  • 批准号:
    10717486
  • 项目类别:
  • 资助金额:
    $50.38万
  • 财政年份:
    2023
  • 负责人:
    Jonathan D. Licht
  • 依托单位:
University of Florida Health Cancer Center Support Grant
  • 批准号:
    10625750
  • 项目类别:
  • 资助金额:
    $213.5万
  • 财政年份:
    2023
  • 负责人:
    Jonathan D. Licht
  • 依托单位:
Developmental Funds
  • 批准号:
    10625759
  • 项目类别:
  • 资助金额:
    $30.5万
  • 财政年份:
    2023
  • 负责人:
    Jonathan D. Licht
  • 依托单位:
国内基金
海外基金
增生性玻璃体视网膜病变早期钙黏蛋白(Cadherins)异常表达启动视网膜色素上皮细胞游离的分子机制
  • 批准号:
    81770939
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2017
  • 负责人:
    王方
  • 依托单位:
Beta-catenin/Cadherins, EphBs 在平衡颅神经嵴细胞的粘附和迁徙机制的研究
  • 批准号:
    81400494
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2014
  • 负责人:
    刘人恺
  • 依托单位:
Cadherins与nectins在青少年期慢性社会应激损害小鼠前额叶形态可塑性与功能中的作用
  • 批准号:
    81401129
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2014
  • 负责人:
    李继涛
  • 依托单位: